In vivo Efficacy of STX213, A Second-Generation Steroid Sulfatase Inhibitor, for Hormone-Dependent Breast Cancer Therapy

PA Foster, SP Newman, SK Chander, C Stengel… - Clinical Cancer …, 2006 - AACR
Purpose: Steroid sulfatase (STS) inhibitors that can decrease or prevent the biosynthesis of
estrogenic steroids via the sulfatase route may play an important role in the treatment of
breast cancer. We compare the in vivo efficacy of two potent STS inhibitors, STX64 and
STX213, in a xenograft breast cancer model. Experimental Design: MCF-7 cells stably
expressing STS cDNA (MCF-7STS) were generated. Ovariectomized MF-1 female nude
mice receiving sc injections of estradiol sulfate (E2S) and bearing both MCF-7STS and wild …

[PDF][PDF] In vivo Efficacy of STX213, A Second-Generation Steroid Sulfatase Inhibitor, for Hormone-Dependent Breast Cancer Therapy

LLW Woo, BVL Potter, MJ Reed, A Purohit - researchgate.net
Purpose: Steroid sulfatase (STS) inhibitors that can decrease or prevent the biosynthesis of
estrogenic steroids via the sulfatase route may play an important role in the treatment of
breast cancer. We compare the in vivo efficacy of two potent STS inhibitors, STX64 and
STX213, in a xenograft breast cancer model. Experimental Design: MCF-7 cells stably
expressing STS cDNA (MCF-7STS) were generated. Ovariectomized MF-1female nude mice
receiving sc injections of estradiol sulfate (E2S) and bearing both MCF-7STS and wild-type …
以上显示的是最相近的搜索结果。 查看全部搜索结果